Hap Trading, LLC Gilead Sciences, Inc. Transaction History

Hap Trading, LLC

$872 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $2.77 Million - $3.15 Million	-35,818 Reduced 59.32%	24,561 $2.04 Million
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $6.47 Million - $9.29 Million	-103,794 Reduced 63.22%	60,379 $5.18 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $6.22 Million - $7.1 Million	104,432 Added 174.81%	164,173 $10.1 Million
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $1.74 Million - $1.96 Million	-30,104 Reduced 33.51%	59,741 $3.69 Million
Q1 2022 May 12, 2022	SELL	$57.92 - $72.58 $9.02 Million - $11.3 Million	-155,767 Reduced 63.42%	89,845 $5.34 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $634,591 - $720,272	9,781 Added 4.15%	245,612 $17.8 Million
Q3 2021 Nov 10, 2021	BUY	$67.69 - $73.03 $13.5 Million - $14.6 Million	199,616 Added 551.2%	235,831 $16.5 Million
Q2 2021 Aug 11, 2021	SELL	$63.47 - $69.35 $1.09 Million - $1.19 Million	-17,141 Reduced 32.13%	36,215 $2.49 Million
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $3.44 Million - $3.93 Million	-57,386 Reduced 51.82%	53,356 $3.45 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $2.28 Million - $2.6 Million	40,244 Added 57.09%	110,742 $6.45 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $4.85 Million - $6.09 Million	-78,030 Reduced 52.54%	70,498 $4.46 Million
Q4 2019 Feb 11, 2020	BUY	$61.62 - $67.78 $466,155 - $512,755	7,565 Added 5.37%	148,528 $9.65 Million
Q3 2019 Nov 12, 2019	SELL	$62.51 - $69.0 $48,632 - $53,682	-778 Reduced 0.55%	140,963 $8.93 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $450,722 - $505,433	-7,285 Reduced 4.89%	141,741 $9.58 Million
Q1 2019 May 10, 2019	BUY	$62.53 - $70.05 $6.91 Million - $7.74 Million	110,506 Added 286.88%	149,026 $9.69 Million
Q3 2018 Nov 09, 2018	SELL	$71.28 - $78.92 $315,271 - $349,063	-4,423 Reduced 10.3%	38,520 $2.97 Million
Q4 2017 Feb 09, 2018	BUY	$71.15 - $83.52 $3.06 Million - $3.59 Million	42,943	42,943 $3.08 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Account